Screener
Fortrea Holdings Inc. FTRE Clinical Services Segment — Segment Operating Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Fortrea Holdings Inc. in its filing.
Tagged under the XBRL concept ftre:SegmentOperatingIncomeLoss.
The source filing: Fortrea Holdings Inc.’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 4:04 PM EST
- Fiscal year
- FY2025
- Accession
- 0001628280-26-012244
| Line item | Years Ended December 31, 2025 | Years Ended December 31, 2024 | Years Ended December 31, 2023 |
|---|---|---|---|
| Direct costs | 1,191.4 | 1,221.7 | 1,275.4 |
| Selling, general and administrative expenses | 397.3 | 415.8 | 392.3 |
| Depreciation | 19.7 | 24.5 | 28.6 |
| Segment operating income | 87.4 | 95.0 | 169.8 |
| Corporate costs not included in segment operating income | 59.7 | 146.0 | 55.9 |
| Amortization | 58.3 | 60.8 | 60.7 |
| Goodwill and other asset impairments | 797.9 | — | — |
| Restructuring and other charges | 44.1 | 50.1 | 21.2 |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is Fortrea Holdings Inc.'s clinical services segment — segment operating income?
- Fortrea Holdings Inc. (FTRE) reported clinical services segment — segment operating income of $21.85M in Q4 2025.
- How has Fortrea Holdings Inc.'s clinical services segment — segment operating income changed year-over-year?
- Fortrea Holdings Inc.'s clinical services segment — segment operating income decreased by 8.0% year-over-year, from $23.75M to $21.85M.
- What is the long-term trend for Fortrea Holdings Inc.'s clinical services segment — segment operating income?
- Over 2 years (2023 to 2025), Fortrea Holdings Inc.'s clinical services segment — segment operating income has grown at a -28.3% compound annual growth rate (CAGR), from $169.8M to $87.4M.
- What does clinical services segment — segment operating income mean?
- This metric represents the operating profit or loss generated specifically by the clinical services segment, calculated by subtracting direct costs and operating expenses from segment revenues. It serves as a key performance indicator for the efficiency and operational success of the company's clinical trial management services. Investors use this to evaluate the core business profitability excluding corporate-level overheads and financing costs.
Ask your AI about Fortrea Holdings Inc.'s clinical services segment — segment operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude